Company

Myriad Genetics

vendor1 tracked tool

life_sciences_drug_discovery category intelligence

Tracked Tools by Myriad Genetics

Myriad Genetics is a molecular diagnostics company specializing in hereditary cancer risk testing (BRACAnalysis, myRisk), prenatal screening, pharmacogenomics (GeneSight), and tumor profiling for treatment selection. The company is a pioneer in BRCA1/BRCA2 genetic testing and provides genetic tests that help oncologists, OB/GYNs, and psychiatrists make personalized treatment decisions across cancer, reproductive health, and mental health.

Company Intelligence

Myriad Genetics Adds F8, FXN Genes to Foresight Universal Plus Panel

5 months agodeployment

New Analysis Published in Peer-reviewed Psychiatry Research Shows Advantages of Combinatorial Algorithm of GeneSight® Psychotropic Test

5 months agoevidence

Digital Health as an Enabler of Personalized Medicine in Ghana: Gaps, Opportunities, and Future Directions

5 months agoevidence